
7percent
Investor participating in BioOrbit's £9.8m seed round.
Last refreshed: 1 May 2026 · Appears in 1 active topic
What investment approach does 7percent Ventures use at seed stage?
Timeline for 7percent
Mentioned in: BioOrbit raises £9.8m for orbital pharma
UK Startups and InnovationWhat does 7percent Ventures invest in?
Why does 7percent take smaller stakes than other VCs?
What is 7percent Ventures and where is it based?
Background
7percent Ventures is a London-based early-stage venture capital investor that focuses on pre-seed and seed rounds, writing smaller cheques and participating alongside larger co-investors in high-conviction syndicates. The fund's name reflects its philosophy of taking a meaningful but non-controlling position in very early-stage companies, preserving founder ownership while securing a stake large enough to drive meaningful returns. It primarily backs technology-led founders in Europe.
7percent typically operates as a participant investor rather than a deal lead, co-investing with established seed funds and accelerators. Its portfolio is concentrated in B2B software, fintech and increasingly deep tech as the European seed landscape has shifted toward Science-led ventures.
7percent participated in BioOrbit's £9.8m in-space drug manufacturing seed in April 2026 as part of the syndicate alongside LocalGlobe, Breega, Auxxo, Seedcamp and Type One. The round is the world's largest seed for in-space manufacturing, enabled by a joint UK regulatory pathway published by four government bodies in March 2026.